BGM0504
A Study of BGM0504 Injection in Participants With Obesity or Overweight
BrightGene Bio-Medical Technology Co · Phase 3 · Completed · Enrollment 652
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.